Development of a Hydrocortisone Orodispersible Thin Film Containing Its Succinate Prodrug
Orodispersible thin film (ODF) is an innovative dosage form that allows for adjustable dosing and improved patient compliance. It is administered by mouth, where it dissolves, making it suitable for children. Objectives: The aim of the study was to develop and characterize an optimal ODF formulation...
Saved in:
Main Authors: | Clément Boisseillier, Lucas Demange-Labriet, Dulanjalee Kariyawasam, Pauline Marchadour, Anne-Sophie Fauqueur, Maxime Annereau, Lucas Denis, Camille Cotteret, Salvatore Cisternino, Arnaud Schweitzer-Chaput |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/1/86 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
by: Analia Yogi, et al.
Published: (2023-10-01) -
Nationwide carrier screening for congenital adrenal hyperplasia: integrated approach of CYP21A2 pathogenic variant genotyping and comprehensive large gene deletion analysis
by: Yossawat Suwanlikit, et al.
Published: (2025-01-01) -
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update
by: Lucas Bouys, et al.
Published: (2025-02-01) -
Semaglutide and laparoscopic sleeve gastrectomy in an adolescent with congenital adrenal hyperplasia due to 21-hydroxylase: a case report
by: Alaina P. Vidmar, et al.
Published: (2025-01-01) -
High clinical utility of long-read sequencing for precise diagnosis of congenital adrenal hyperplasia in 322 probands
by: Yunpeng Wang, et al.
Published: (2025-01-01)